TENX
TENX
NASDAQ · Biotechnology

Tenax Therapeutics Inc

$13.92
+0.42 (+3.11%)
As of Jun 30, 3:31 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +139.4% upside
Low Target $30.09
Average Target $33.33
High Target $42.13
Current Price $13.92
Current
$13.92
Target
$33.33
$30.09 $33.33 avg $42.13
Scenario Analysis
Bear Case
$30.09
116.2%
Low target
Base Case
$33.33
+139.4%
Avg target
Bull Case
$42.13
+202.7%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$18.38
-24.3% from high
52-Week Low
$5.62
+147.9% from low
Target vs 52W High
$33.33
+81.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%